Abstract
The efficacy of endoscopic injection sclerotherapy (EIS) was studied in 126 patients who underwent treatment with EIS for esophageal and gastric varicies. A second EIS was performed in 15 of 38 patients without hemorrhage after palliative treatment for liver cirrhosis (LC) and idiopathic portal hypertension (IPH) and in seven of 32 patients without hemorrhage after palliative treatment for hepatoma (HCC), about eight months and nine months, respectively, after the initial EIS. Hemorrhage was observed in five (13%) patients with LC or IPH and 10(24%) with HCC, about eight months and three months, respectively, after EIS as palliative treatment. The incidences of emergency hemostasis were 92% and 73% for patients with LC and IPH and HCC, respectively. Some patients with hemorrhage or rehemorrhage showed specific hemodynamic changes. The necessity of additional EIS should therefore be evaluated by endoscopy every 3 to 6 months after EIS, simultaneously with detailed examination of portal hemodynamic changes. If necessary, other therapeutic methods should be used with EIS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The journal of the Japanese Practical Surgeon Society
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
